ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 185 filers reported holding ARIAD PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $138,000 | -13.8% | 11,075 | -5.4% | 0.00% | 0.0% |
| Q3 2016 | $160,000 | +83.9% | 11,708 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $87,000 | +20.8% | 11,708 | +3.2% | 0.00% | – |
| Q1 2016 | $72,000 | -2.7% | 11,341 | -4.7% | 0.00% | – |
| Q4 2015 | $74,000 | +2.8% | 11,902 | -3.9% | 0.00% | – |
| Q3 2015 | $72,000 | -29.4% | 12,383 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $102,000 | -2.9% | 12,383 | -3.1% | 0.00% | 0.0% |
| Q1 2015 | $105,000 | +19.3% | 12,784 | 0.0% | 0.00% | – |
| Q4 2014 | $88,000 | +22.2% | 12,784 | -3.9% | 0.00% | – |
| Q3 2014 | $72,000 | -15.3% | 13,297 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $85,000 | – | 13,297 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,331,100 | $23,281,000 | 8.28% |
| DAFNA Capital Management LLC | 191,215 | $3,344,000 | 4.89% |
| Redmile Group, LLC | 1,277,109 | $22,337,000 | 3.94% |
| BB BIOTECH AG | 3,115,371 | $54,488,000 | 3.92% |
| SECTORAL ASSET MANAGEMENT INC | 5,292,682 | $92,569,000 | 2.74% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 565,956 | $9,899,000 | 1.76% |
| OAK RIDGE INVESTMENTS LLC | 2,645,781 | $46,275,000 | 1.45% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,265,104 | $22,127,000 | 1.04% |
| Tekla Capital Management LLC | 412,965 | $7,223,000 | 0.98% |
| Private Capital Advisors, Inc. | 127,600 | $2,232,000 | 0.83% |